BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4436850
Number of visits today
2498
Number of downloads
4069485
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pooresmaeil M, Namazi H. Developing a new photoluminescent, nanoporous, and biocompatible glycodendrimer for smart hepatic cancer treatment. European Polymer Journal 2021;161:110866. [DOI: 10.1016/j.eurpolymj.2021.110866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Karimi S, Namazi H. Targeted co-delivery of doxorubicin and methotrexate to breast cancer cells by a pH-sensitive biocompatible polymeric system based on β-cyclodextrin crosslinked glycodendrimer with magnetic ZnO core. European Polymer Journal 2022;176:111435. [DOI: 10.1016/j.eurpolymj.2022.111435] [Reference Citation Analysis]
2 Toomari Y, Ebrahimpour H, Pooresmaeil M, Namazi H. D-glucose functionalized β-cyclodextrin as a controlled anticancer drug carrier for in vitro evaluation. Polym Bull . [DOI: 10.1007/s00289-022-04280-5] [Reference Citation Analysis]
3 Pooresmaeil M, Namazi H, Salehi R. Dual anticancer drug delivery of D-galactose-functionalized stimuli-responsive nanogels for targeted therapy of the liver hepatocellular carcinoma. European Polymer Journal 2022;167:111061. [DOI: 10.1016/j.eurpolymj.2022.111061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
4 Ebrahimpour H, Toomari Y, Pooresmaeil M, Namazi H. Cluster of D-maltose clicked to β-cyclodextrin: preparation and its application as a biocompatible drug delivery nanovehicle. Soft Materials. [DOI: 10.1080/1539445x.2021.2019056] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345